A carregar...
Brief report: RRx-001 is a c-Myc inhibitor that targets cancer stem cells
The goal of anticancer therapy is to selectively eradicate all malignant cells. Unfortunately for the majority of patients with metastatic disease, this goal is consistently thwarted by the nearly inevitable development of therapeutic resistance; the main driver of therapeutic resistance is a minori...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5955127/ https://ncbi.nlm.nih.gov/pubmed/29805745 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25211 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|